Canertinib

• Target :

  EGFR|||Virus Protease

• Related Pathways :

  Microbiology/Virology|||JAK/STAT signaling|||Tyrosine Kinase/Adaptors|||Angiogenesis

• Purity :

  >99.99%

• Bioactivity :

  Canertinib (CI-1033) is a pan-erbB tyrosine kinase inhibitor which work against esophageal squamous cell carcinoma in vitro and in vivo. Canertinib treatment significantly affects tumour metabolism, proliferation and hypoxia as determined by PET.

• Smiles :

  Fc1ccc(Nc2ncnc3cc(OCCCN4CCOCC4)c(NC(=O)C=C)cc23)cc1Cl

• Molecular Formula :

  C24H25ClFN5O3

• Molecular Weight :

  485.94

• Shipping Conditions :

  Cool pack

• Storage Temperature :

  -20°C

• CAS Number :

  267243-28-7